Effect of Evolocumab on Non‐High‐Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a): A Pooled Analysis of Phase 2 and Phase 3 Studies

Apolipoprotein B ◽

Density Lipoprotein ◽

Pooled Analysis ◽

High Density ◽

Lipoprotein Cholesterol ◽

Phase 2 ◽

Phase 3 ◽

Lipoprotein A

Alirocumab Treatment and Achievement of Non‐High‐Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials

Journal of the American Heart Association ◽

10.1161/jaha.117.005639 ◽

2017 ◽

Vol 6 (8) ◽

Cited By ~ 10

Author(s):

Harold E. Bays ◽

Lawrence A. Leiter ◽

Helen M. Colhoun ◽

Desmond Thompson ◽

Laurence Bessac ◽

...

Keyword(s):

Apolipoprotein B ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol ◽

Phase 3

Inverse Relationship Between Major Adverse Cardiovascular Events and non-High-Density Lipoprotein Cholesterol and Apolipoprotein B in Phase 3 Trials of Alirocumab

Journal of Clinical Lipidology ◽

10.1016/j.jacl.2016.03.107 ◽

2016 ◽

Vol 10 (3) ◽

pp. 724

Author(s):

Michael H. Davidson ◽

Christopher P. Cannon ◽

Henry N. Ginsberg ◽

Robert Pordy ◽

Laurence Bessac ◽

...

Keyword(s):

Apolipoprotein B ◽

Cardiovascular Events ◽

Inverse Relationship ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol ◽

Major Adverse Cardiovascular Events ◽

Phase 3

Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B: relationships among the different measurements

Scandinavian Journal of Clinical and Laboratory Investigation ◽

10.1080/00365510410003011 ◽

2004 ◽

Vol 64 (8) ◽

pp. 703-708 ◽

Cited By ~ 1

Author(s):

C. Franzini ◽

C. Valente ◽

P. Luraschi

Keyword(s):

Low Density Lipoprotein Cholesterol

Apolipoprotein B ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Comparisons of Apolipoprotein B Levels Estimated by Immunoassay, Nuclear Magnetic Resonance, Vertical Auto Profile, and Non-High-Density Lipoprotein Cholesterol in Subjects With Hypertriglyceridemia (SAFARI Trial)

The American Journal of Cardiology ◽

10.1016/j.amjcard.2011.03.003 ◽

2011 ◽

Vol 108 (1) ◽

pp. 40-46 ◽

Cited By ~ 23

Author(s):

Scott M. Grundy ◽

Gloria Lena Vega ◽

Joanne E. Tomassini ◽

Andrew M. Tershakovec

Keyword(s):

Nuclear Magnetic Resonance ◽

Magnetic Resonance ◽

Apolipoprotein B ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol ◽

Nuclear Magnetic

High apolipoprotein B with low high-density lipoprotein cholesterol and normal plasma triglycerides and cholesterol

The American Journal of Cardiology ◽

10.1016/s0002-9149(00)01508-3 ◽

2001 ◽

Vol 87 (6) ◽

pp. 792-793 ◽

Cited By ~ 21

Author(s):

Allan D Sniderman ◽

Gilles R Dagenais ◽

Bernard Cantin ◽

Jean-Pierre Després ◽

Benoı̂t Lamarche

Keyword(s):

Apolipoprotein B ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol ◽

Plasma Triglycerides ◽

Normal Plasma

The amount of cholesterol relative to apolipoprotein B in low-density lipoproteins relates primarily to high-density lipoprotein cholesterol in children: The Bogalusa Heart Study

Metabolism ◽

10.1016/0026-0495(94)90187-2 ◽

1994 ◽

Vol 43 (8) ◽

pp. 1042-1046 ◽

Cited By ~ 5

Author(s):

Sathanur R. Srinivasan ◽

Weihang Bao ◽

Gerald S. Berenson

Keyword(s):

Apolipoprotein B ◽

Density Lipoprotein ◽

Low Density Lipoproteins ◽

High Density ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Bogalusa Heart Study ◽

Heart Study

Potential effects on clinical management of treatment algorithms on the basis of apolipoprotein-B/A-1 and total/high-density lipoprotein-cholesterol ratios

Journal of Clinical Lipidology ◽

10.1016/j.jacl.2011.02.004 ◽

2011 ◽

Vol 5 (3) ◽

pp. 159-165 ◽

Cited By ~ 3

Author(s):

Deepthi Vodnala ◽

Robert L. Bard ◽

Sangeetha M. Krishnan ◽

Elizabeth A. Jackson ◽

Melvyn Rubenfire ◽

...

Keyword(s):

Apolipoprotein B ◽

Clinical Management ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol ◽

Treatment Algorithms

Disparate effects of interleukin-3 on serum lipoprotein(a), and low- and high-density lipoprotein cholesterol levels

The American Journal of Cardiology ◽

10.1016/0002-9149(95)80043-r ◽

1995 ◽

Vol 75 (4) ◽

pp. 296-297 ◽

Cited By ~ 1

Author(s):

Peter Riis Hansen ◽

Doris Hovgaard

Keyword(s):

Density Lipoprotein ◽

Serum Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol ◽

Lipoprotein A ◽

Interleukin 3 ◽

Cholesterol Levels

Discordance analysis of Apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study

Atherosclerosis ◽

10.1016/j.atherosclerosis.2012.08.039 ◽

2012 ◽

Vol 225 (2) ◽

pp. 444-449 ◽

Cited By ~ 60

Author(s):

Allan D. Sniderman ◽

Shofique Islam ◽

Salim Yusuf ◽

Matthew J. McQueen

Keyword(s):

Cardiovascular Risk ◽

Apolipoprotein B ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol

P3462Are extremely elevated serum high density lipoprotein cholesterol protective against atherosclerotic diseases in a large pooled analysis of nine Japanese cohorts?

European Heart Journal ◽

10.1093/eurheartj/ehx504.p3462 ◽

2017 ◽

Vol 38 (suppl_1) ◽

Author(s):

T. Okamura ◽

A. Hirata ◽

Y. Murakami ◽

K. Miura ◽

H. Iso ◽

...

Keyword(s):

Elevated Serum ◽

Density Lipoprotein ◽

Pooled Analysis ◽

High Density ◽

Lipoprotein Cholesterol ◽

Serum High Density Lipoprotein